Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Concord Medical CoROCO:6518 -0.65%71 FCF Margin % is 13.24% as of Dec. 2025, which is 82% above its 10-year median of 7.29. GuruFocus rates ROCO:6518 with a GF Score™ of 71/100 and a GF Value™ of NT$29.15 (Fairly Valued). The stock has 3 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Concord Medical Co ranks better than 79.88% on this metric.
The historical rank and industry rank for Concord Medical Co's FCF Margin % or its related term are showing as below:
ROCO:6518'
s FCF Margin % Range Over the Past 10 Years
Min: -2.21 Med: 7.29 Max: 15.63
Current: 12.65
During the past 13 years, the highest FCF Margin % of Concord Medical Co was 15.63%. The lowest was -2.21%. And the median was 7.29%.
ROCO:6518's FCF Margin % is ranked better than 79.88% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: -0.56
vs ROCO:6518: 12.65
Concord Medical Co FCF Margin % Related Terms
Concord Medical Co FCF Margin % Historical Data
* Premium members only.
The historical data trend for Concord Medical Co's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6518 vs ISRG, BDX, MDLN: FCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, Concord Medical Co's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Concord Medical Co FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Concord Medical Co's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Concord Medical Co's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Concord Medical Co (ROCO:6518) has a FCF Margin % of 13.24% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Concord Medical Co and its competitors. This is 82% above median its historical median of 7.29. According to the industry distribution chart, Concord Medical Co ranks #164 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 20.1%.
Is Concord Medical Co's FCF Margin % too high?
Concord Medical Co's current FCF Margin % of 13.24% is 82% above median its 10-year median of 7.29. Based on the distribution chart, Concord Medical Co ranks #164 out of 815 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Concord Medical Co has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Concord Medical Co's FCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Concord Medical Co ranks #164 out of 815 companies for FCF Margin %. This places Concord Medical Co in the top 20% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Concord Medical Co and its competitors. Concord Medical Co's current FCF Margin % is 13.24%, which is 82% above median its own 10-year median of 7.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Concord Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Concord Medical Co (ROCO:6518) is currently considered Fairly Valued. The stock's GF Value™ is NT$29.15, compared to a current price of NT$30.40 — trading 4.3% above its estimated fair value. The current FCF Margin % is 13.24%, which is 82% above median its 10-year median of 7.29. Concord Medical Co's overall GF Score™ is 71/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Concord Medical Co (ROCO:6518), the current FCF Margin % is 13.24% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Concord Medical Co (ROCO:6518) Overvalued in 2026?
Based on GuruFocus' analysis, Concord Medical Co stock appears to be overvalued.
The current stock price of NT$30.40 is trading 4.3% above its estimated GF Value™ of NT$29.15.
GuruFocus considers Concord Medical Co to be Fairly Valued.
Key valuation signals for ROCO:6518:
FCF Margin %: 13.24% (82% above median its 10-year median of 7.29)
GF Value™: NT$29.15 vs. price of NT$30.40 (4.3% above fair value)
No single metric tells the full story. See the ROCO:6518 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Concord Medical Co Ltd is a Taiwan based company involved in providing hospital management support services including medical equipment leasing, pharmaceuticals, and medical consumables integrated supply. . The company's main business items are medical equipment, pharmaceuticals Product trading business, leasing business and management consulting services.
71GF Score
Get the complete analysis for ROCO:6518
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6518 has been successfully added to your 
